Zymergen
Harnessing nature to innovate materials and products for diverse industries, from agriculture and electronics to consumer care and pharmaceuticals
Harnessing nature to innovate materials and products for diverse industries, from agriculture and electronics to consumer care and pharmaceuticals
Zymergen is a biotechnology company founded in 2013 with the slogan "Harnessing nature to innovate materials and products for diverse industries, from agriculture and electronics to consumer care and pharmaceuticals." The company's core focus lies in machine learning, big data, and artificial intelligence, allowing them to collaborate with nature in creating materials and products for a wide range of industries including agriculture, electronics, consumer care, pharmaceuticals, and more.
The company recently received a significant $300.00M Series D investment on 08 September 2020 from a group of prominent investors including DCVC, True Ventures, Baillie Gifford, Baron Capital, Perceptive Advisors, SoftBank Vision Fund, and Employee Stock Option Fund. With this injection of funds, Zymergen is well-positioned to expand its pioneering work at the intersection of biotechnology, data science, and the development of innovative materials and products.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series D | $300.00M | 7 |
|
08 Sep 2020 |
| Debt Financing | $100.00M | 1 |
|
01 Jan 2020 |
| Series C | $400.00M | 10 |
|
13 Dec 2018 |
| Series B | $130.00M | 10 |
|
11 Oct 2016 |
| Series A | $42.14M | 9 |
|
16 Jun 2015 |
We care about your data, and we'd love to use cookies make your experience better.
